Pfizer, Flynn Pharma, UK watchdog granted appeals in long-running pricing case
Pfizer, Flynn Pharma and the UK's Competition and Markets Authority have won appeals against a court ruling in the latest chapter in their long-running epilepsy drug pricing case. The companies were...To view the full article, register now.
Already a subscriber? Click here to view full article